Tag: Inflammation and rare disease study
Amgen Conference Call: New Topline Data in Inflammation and Rare Disease
Amgen (NASDAQ: AMGN) has scheduled a webcasted conference call for the investment community on Tuesday, September 24, 2024, at 1:30 p.m. PT. The purpose...